Short-term and intermediate-term therapy with cannabinoids can be considered in selected patients with chronic neuropathic pain after failure of first-line and second-line therapies. Cannabinoids were marginally superior to placebo in terms of efficacy and inferior in terms of tolerability.
Link: Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain : A systematic review of randomized controlled studies
Year: 2016
DOI: 10.1007/s00482-015-0089-y
Likely probability of the efficacy of cannabis for treatment of Pain (Neuropathies, in general) according to the results found in this study.
Medicinal cannabis, plant-based or synthetic cannabinoids with placebo or any other active drug treatment in patients with chronic neuropathic pain.